Abnormal glucose tolerance – a common risk factor in patients with acute myocardial infarction in comparison with population‐based controls
Open Access
- 13 September 2004
- journal article
- Published by Wiley in Journal of Internal Medicine
- Vol. 256 (4) , 288-297
- https://doi.org/10.1111/j.1365-2796.2004.01371.x
Abstract
Background. A high prevalence of newly detected diabetes and impaired glucose tolerance (abnormal glucose tolerance) was recently reported in patients with acute myocardial infarction. It is important to verify whether this finding is specific for the patients or attributable to the population, from which they were recruited. Objective. To verify whether abnormal glucose tolerance is more prevalent in patients than in controls chosen from the same population and to compare metabolic characteristics between the two groups. Design and subjects. The metabolic state was assessed in patients (n = 181) admitted with acute myocardial infarction and no history of diabetes before discharge and after 3 months. Sex- and age-matched controls (n = 185) without previously known diabetes or cardiovascular disease except hypertension were recruited from the general population. Main outcome measures. Oral glucose tolerance test, glucosylated haemoglobin A1c (HbA1c), insulin, proinsulin, lipid profile, fibrinolytic function and inflammatory markers. Results. Abnormal glucose tolerance was more common (number/all classified) in patients at discharge 113/168 (67%) and after 3 months 95/145 (66%) than in controls 65/185 (35%) (P < 0.001). Dyslipidaemia (70% vs. 29%; P < 0.001) and previously treated hypertension (32% vs. 18%; P = 0.028) were more frequent amongst patients whilst obesity (18% vs. 24%) did not differ significantly. Blood glucose, HbA1c, proinsulin, proinsulin/insulin ratio, triglycerides, insulin resistance (by HOMA) and fibrinogen were consistently higher in patients than controls (P < 0.01). Conclusions. Abnormal glucose tolerance was almost twice as common amongst patients with acute myocardial infarction as in matched controls. Impaired glycaemic control accompanied by insulin resistance, dyslipidaemia, hypertension, together with increased plasma fibrinogen and proinsulin levels were main features characterizing patients.Keywords
This publication has 46 references indexed in Scilit:
- hsCRP and HDL Effects of Statins Trial (CHEST): Rapid Effect of Statin Therapy on C-Reactive Protein and High-Density Lipoprotein LevelsHeart Disease, 2003
- Einfluss einer eingeschränkten Glukosetoleranz auf das Langzeitüberleben nach akutem Myokardinfarkt1 - The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA) -Deutsche Medizinische Wochenschrift (1946), 2002
- Plasminogen-Activator Inhibitor Type 1 and Coronary Artery DiseaseNew England Journal of Medicine, 2000
- Type 2 diabetes and macrovascular disease: Epidemiology and etiologyAmerican Heart Journal, 1999
- Effects of a cardioselective β-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular riskAtherosclerosis, 1998
- The relation of proinsulin, insulin, and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjectsDiabetes, 1997
- Relation of High TG–Low HDL Cholesterol and LDL Cholesterol to the Incidence of Ischemic Heart DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Hyperproinsulinemia is associated with increased beta cell demand after hemipancreatectomy in humans.Journal of Clinical Investigation, 1996
- Relation of angiographically defined coronary artery disease and plasma concentrations of insulin, lipid, and apolipoprotein in normolipidemic subjects with varying degrees of glucose toleranceThe American Journal of Cardiology, 1995
- Relationship of proinsulin and insulin to cardiovascular risk factors in nondiabetic subjectsDiabetes, 1993